Atypical and anaplastic meningiomas in a public hospital in São Paulo state, Brazil
Arquivos de Neuro-Psiquiatria, ISSN: 1678-4227, Vol: 73, Issue: 9, Page: 770-778
2015
- 5Citations
- 10,485Usage
- 24Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Atypical/anaplastic (World Health Organization (WHO) grades II and III) are less common and have poorer outcomes than benign meningiomas. This study aimed to analyze the outcome of patients with these tumors. Method: Overall/recurrence-free survivals (RFS) and the Karnofsky Performance Scale of 52 patients with grades II (42) and III (9) meningiomas surgically treated were analyzed (uni/multivariate analysis). Results: Total/subtotal resections were 60.8%/35.3%. Patients <60 years-old and grade II tumors had longer survival. Grade II tumors, total resection and de novo meningioma had better RFS (univariate analysis). Patients >60 years-old, de novo meningioma and radiotherapy had longer survival and patients <60 years-old and with grade II tumors had longer RFS (multivariate analysis). Recurrence rate was 51% (39.2% Grade II and 66.7% Grade III). Operative mortality was 1.9%. Conclusion: Age <60 years-old, grade II tumors and de novo meningiomas were the main predictors for better prognosis among patients with grades II and III meningiomas.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84940941703&origin=inward; http://dx.doi.org/10.1590/0004-282x20150106; http://www.ncbi.nlm.nih.gov/pubmed/26352496; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900770&lng=en&tlng=en; http://www.scielo.br/pdf/anp/v73n9/0004-282X-anp-73-9-0770.pdf; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-282X2015000900770&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900770; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-282X2015000900770; https://dx.doi.org/10.1590/0004-282x20150106; https://www.scielo.br/j/anp/a/3vTPnF8xPDCVwby6FbkxgpM/?lang=en
FapUNIFESP (SciELO)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know